THE SHORT ANSWER
Do ACA (Obamacare) Marketplace Plans Cover Foundayo?
Coverage Is Rare—And Declining in 2026
Only a small minority of Marketplace carriers cover GLP-1 weight loss medications in 2026—and access is shrinking. GLP-1s (like Foundayo, Wegovy, and Zepbound) are a newer class of medications that help control appetite and support weight loss. When covered, most require prior authorization (pre-approval from your insurer before filling the prescription).
The Affordable Care Act requires Marketplace plans to cover 10 essential health benefits—but weight loss medications are not considered essential and are routinely excluded.[9]
For context: across all commercial insurance (including employer plans), GoodRx research shows 51% of people have no coverage for Foundayo as of November 2025—and Marketplace plans are even more restrictive than employer plans.[2]
- Individual and family Marketplace plans almost never cover weight loss drugs
- Coverage requirements are strict: Most plans require BMI ≥30, or BMI ≥27 with a qualifying health condition, plus documented diet/exercise attempts
- If covered at all, 100% require you to get pre-approval first
Bottom line: Don't assume your Marketplace plan will cover Foundayo—and coverage is getting harder to find in 2026. Before enrolling or filling a prescription, verify coverage using the steps below.
The Mounjaro Workaround
If you also have type 2 diabetes, your plan might cover Mounjaro (tirzepatide)—a different GLP-1 medication made by Eli Lilly. While Mounjaro is FDA-approved for diabetes (not weight loss), many patients experience significant weight loss on it. Ask your doctor if this option makes sense for you.
For a complete overview of getting Foundayo covered regardless of insurer, see our full coverage guide.
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get starteddenied approved
Honest Care helps patients fight back:
Evidence-backed appeal letters — plus personalized guidance to appeal with confidence.
"I found Honest Care online and was very impressed with the letter... the appeal worked!"
"My Appeal was approved the next day. Thank you Honest Care!"
STEP-BY-STEP ON HEALTHCARE.GOV
How to Check Coverage
Before enrolling in a Marketplace plan, you can check if Foundayo is covered by looking at the plan's formulary (the official list of drugs the plan covers). Here's how:
Note: These steps are for Healthcare.gov (used in most states). If your state runs its own marketplace (like California, New York, or Colorado), visit your state's exchange website instead—the process is similar.
Go to Healthcare.gov
Visit Healthcare.gov and start your application or log in to your existing account. Enter your ZIP code and household information to see available plans in your area.
Select a Plan to Review
Browse the available plans and click on one you're considering. Look for the "View benefits and coverage" or "Plan details" link.
Find the Drug Formulary
Look for a link labeled "Drug List (Formulary)" or "Covered medications." This is usually a downloadable PDF containing all covered drugs.
Search for Foundayo
Open the formulary PDF and use your browser's search function (Ctrl+F on PC, Cmd+F on Mac) to look for "Foundayo" or "orforglipron" (the generic name). If you find it, check:
- Is it listed for weight loss or only for diabetes?
- Does it require pre-approval or trying other drugs first?
- What tier is it on? (Higher tiers = higher copays)
Call to Confirm
Even if Foundayo appears on the formulary, call the plan's customer service to confirm coverage for weight loss specifically. Some plans may cover other GLP-1 medications for diabetes but not Foundayo for weight loss.
What to Say When You Call
"Hi, I'm thinking about enrolling in [PLAN NAME] and I need to check if a specific medication is covered. Can you help me with these questions?"
- "Does this plan cover Foundayo for weight loss?"
- "Is it on the drug list? What tier?"
- "Do I need pre-approval before I can fill the prescription?"
- "What do I need to qualify—a certain BMI or health conditions?"
- "Can you email me this information so I have it in writing?"
Pro tip: Get confirmation in writing or note the date, representative's name, and reference number. Verbal confirmations aren't binding.
Alternative: You can also use Lilly's coverage checker tool to verify if your specific insurance plan covers Foundayo—have your prescription card handy.[3]
WHICH TIERS ARE MOST LIKELY TO COVER?
Metal Tier Comparison
Marketplace plans are organized into four "metal tiers" based on how costs are split between you and the insurance company. Here's how each tier typically handles Foundayo:
| Metal Tier | Premium | Foundayo Coverage | Notes |
|---|---|---|---|
| Bronze | Lowest | Very Unlikely | Minimal formularies; almost never covers weight loss drugs |
| Silver | Low-Mid | Unlikely | Most popular tier; still typically excludes weight loss |
| Gold | Mid-High | Rare but possible | Broader formularies; some may cover with prior authorization |
| Platinum | Highest | Rare but possible | Most comprehensive; best chance (still <1%) |
Why Higher Tiers Aren't Much Better
While Gold and Platinum plans have broader formularies and lower cost-sharing, the decision to cover weight loss medications is made at the plan level—not the tier level. Most ACA insurers exclude these drugs across all their metal tiers.
Don't choose a more expensive plan solely for Foundayo coverage without verifying it's actually on the formulary.
What About Subsidies?
If you qualify based on income, the government can help pay part of your monthly premium (this is called a "subsidy" or "premium tax credit"). However:
- Subsidies don't change which drugs are covered—the plan's drug list stays the same whether you get help paying or not
- Extra savings on Silver plans can reduce your copays, but they won't add Foundayo to the drug list if it's not already covered
- Bottom line: Subsidies help with your monthly bill, not Foundayo coverage
2026 DEADLINES & HOW TO ENROLL
Open Enrollment
You can only enroll in or switch Marketplace plans during specific periods:
2026 Open Enrollment Dates
November 1, 2025 – January 15, 2026[8]
- Enroll by December 15, 2025 → Coverage starts January 1, 2026
- Enroll December 16, 2025 – January 15, 2026 → Coverage starts February 1, 2026
Special Enrollment Periods (SEPs)
Outside of Open Enrollment, you can enroll or switch plans if you have a qualifying life event:
Qualifying Life Events
- Loss of other coverage (job loss, aging off parent's plan)
- Marriage or divorce
- Birth or adoption of a child
- Moving to a new ZIP code or county
- Change in income affecting subsidy eligibility
- Loss of Medicaid or CHIP (Children's Health Insurance Program) coverage
You typically have 60 days from the qualifying event to enroll.
Should You Switch Plans for Foundayo?
If you're currently on a Marketplace plan that doesn't cover Foundayo, consider during Open Enrollment:
- Check if ANY Marketplace plans in your area cover it (use the formulary search steps above)
- Compare total costs—a higher premium plan that covers Foundayo may still cost less than paying out-of-pocket ($1,000+/month)
- Consider alternatives—if no Marketplace plans cover Foundayo, explore self-pay options like Lilly's savings programs
YOUR APPEAL RIGHTS
If Your Plan Denies Foundayo
Appeals Work
39-59% of commercial insurance appeals succeed when patients fight back—and KFF analysis shows 44% for ACA Marketplace plans specifically. Under the ACA, you have a legal right to appeal any coverage denial—and the process is free.[4][5]
If your Marketplace plan denies Foundayo, here's what to do:
Request the Denial in Writing
Get a written explanation with the specific reason for denial. Common reasons include:
- "Not medically necessary"
- "Excluded benefit" (the plan doesn't cover weight loss drugs at all)
- "Does not meet criteria" (you don't meet BMI or health condition requirements)
- "Step therapy not completed" (you must try cheaper drugs first)
File an Internal Appeal
Under federal law, you have 180 days (6 months) to file an appeal.[6] The insurance company must have someone new review your case—not the same person who denied you the first time.
Your appeal should include:
- A letter from you explaining why you need Foundayo
- A letter from your doctor explaining why it's medically necessary
- Your health information (BMI, weight-related conditions, what you've already tried)
- Research showing Foundayo works for people like you
Request External Review (If Needed)
If your appeal is denied, you can ask for an external review. This means an independent reviewer (not your insurance company) looks at your case. Here's what's great about it:
- It's free—you don't pay anything
- It's final—if they rule in your favor, your insurance company must cover you
- It's fast—they must decide within 45 days (or 72 hours if it's urgent)[7]
What If Your Plan Excludes All Weight Loss Drugs?
If your plan doesn't cover any weight loss medications (not just Foundayo), an appeal probably won't work. But you still have options:
- Switch plans during Open Enrollment to one that does cover weight loss drugs
- If you have sleep apnea—ask about Zepbound (tirzepatide), which is FDA-approved for obstructive sleep apnea. Foundayo is approved only for chronic weight management, not sleep apnea
- Check Medicaid—if you qualify based on income, California Medi-Cal covers Foundayo (check your state's Medicaid too)[3]
- Pay out-of-pocket—Lilly offers Foundayo via LillyDirect starting at $149/month[3]
Have Insurance But No Foundayo Coverage?
If you have commercial insurance (like a Marketplace plan) but your plan doesn't cover Foundayo, you may still qualify for Lilly's Savings Card. Note: 2026 savings caps have been reduced. Monthly savings are now capped at $100/month (down from $150 in 2025), with an annual cap of $1,000/year. Maximum 10 fills per year.[3]
The self-pay option through LillyDirect at $149–$299/month may be more affordable than retail pricing.
Important: The savings card expires December 31, 2026. Check Lilly's website for current terms.
For detailed appeal strategies, see our complete Foundayo appeals guide.
denied approved
Honest Care helps patients fight back:
Evidence-backed appeal letters — plus personalized guidance to appeal with confidence.
WHAT'S CHANGING
2026 Outlook
Marketplace GLP-1 coverage is declining in 2026, not expanding. Several major insurers have announced they're dropping weight loss drug coverage effective January 1, 2026, citing unsustainable costs.[10]
Major Insurers Dropping Coverage in 2026
Coverage Cuts Announced
- Blue Cross Blue Shield of Massachusetts — Ending coverage for Wegovy, Saxenda, and Zepbound for weight loss (continues for diabetes/CVD)[10]
- NH Healthy Families — Ending weight loss medication coverage January 1, 2026
- MVP of Vermont — Removing GLP-1 weight loss coverage
- Milton, MA plans — Excluding all GLP-1s except for type 2 diabetes
Insurers cite high costs as the primary driver—BCBS of Massachusetts alone spent over $300 million on five GLP-1 drugs in 2024. Premium reductions of approximately 3% are expected from these cuts.[10]
States With Marketplace GLP-1 Coverage
A limited number of states have some Marketplace plans covering GLP-1s for obesity in 2026. States with reported coverage include:
- California — Some carriers may cover with restrictions
- North Dakota — Reported broader coverage options
- New York — Some carrier coverage
- Vermont — Coverage varies; some carriers dropping
- Pennsylvania — Some carriers may cover
Note: Coverage changes frequently. Always verify with specific carriers during Open Enrollment.
If you're in one of these states, check formularies carefully during Open Enrollment—coverage varies significantly by carrier and plan.
Medicare Coverage: The GLP-1 Bridge (Live Now)
Medicare and weight-loss GLP-1s: the Medicare GLP-1 Bridge
Through the Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027), a temporary CMS demonstration that runs outside the Part D benefit, people with eligible Part D coverage can get Wegovy, Foundayo or the Zepbound KwikPen for weight loss for $50 a month, if they meet CMS’s eligibility criteria and their prescriber gets prior authorization.
- Who qualifies: Age 18+ and BMI ≥35; or BMI ≥30 with HFpEF, uncontrolled high blood pressure or CKD stage 3a+; or BMI ≥27 with prediabetes, a prior heart attack or stroke, or symptomatic PAD.
- Who doesn’t: Not eligible if you have type 2 diabetes, moderate-to-severe obstructive sleep apnea, or noncirrhotic MASH with moderate-to-advanced liver fibrosis (F2–F3), or if your Part D plan paid for a GLP-1 for you at any time in 2026.
- Cost: $50 per monthly fill. Does not count toward the Part D deductible or out-of-pocket cap. Extra Help (LIS) does not lower it. Not eligible for the Medicare Prescription Payment Plan. Coupons and discount programs can’t be applied.
- No opt-in needed: Part D plans and pharmacies don’t opt in, and you don’t enroll separately; your prescriber must get prior authorization.
- If it’s denied: No appeals process for a Bridge prior-authorization denial: your prescriber can resubmit with more information (Part D appeal rights for Part D coverage decisions still apply).
Source: CMS, Medicare GLP-1 Bridge · Facts in this box verified October 5, 2026
Note: The Medicare GLP-1 Bridge doesn't affect ACA Marketplace plans. For now, Marketplace coverage remains limited.
MARKETPLACE FOUNDAYO COVERAGE
Frequently Asked Questions
Rarely, and coverage is declining. Only about 8.7% of Marketplace carriers (26 out of 300) cover GLP-1 weight loss medications like Foundayo in 2026—down from previous years. Weight loss drugs aren't considered "essential" under the Affordable Care Act, so most plans exclude them. When covered, 100% require prior authorization, and most require BMI ≥30 (or BMI ≥27 with a qualifying health condition) plus documented diet/exercise attempts.
On Healthcare.gov, select a plan and look for the "Drug List" or "Formulary" link. Search for "Foundayo" in that list. Even if you find it, call the plan to make sure it's covered for weight loss—some plans cover GLP-1s only for diabetes. You can also use Lilly's free coverage checker.
Not really. Higher-tier plans have broader drug lists, but coverage for weight loss drugs is decided by each insurance company—not by tier. Most insurers exclude Foundayo across all their plans. Don't pay for a more expensive plan just for Foundayo unless you've confirmed it's actually covered.
Open Enrollment for 2026 coverage runs November 1, 2025 through January 15, 2026. Sign up by December 15, 2025 to have coverage start January 1, 2026. Outside Open Enrollment, you can only sign up if you have a major life change (like losing other coverage, getting married, or having a baby)—you'll have 60 days to enroll.
Yes, and you should. About 44% of appeals succeed for Marketplace plans. You have 6 months to file an appeal, and if that fails, you can request an external review where an independent reviewer makes the final call—and their decision is binding on your insurer. However, if your plan excludes all weight loss drugs, an appeal is unlikely to help.
No. Subsidies (premium tax credits) lower your monthly insurance bill, but they don't change which drugs are covered. The plan's drug list is the same whether you get financial help or not. If you can't get coverage, Lilly offers Foundayo starting at $149/month through LillyDirect. Note that the 2026 savings card caps have been reduced to $100/month (max $1,000/year, 10 fills).
A limited number of states have some Marketplace plans covering GLP-1s for obesity in 2026, including California, North Dakota, New York, Vermont, Pennsylvania, and others. Coverage varies significantly by carrier, so check formularies during Open Enrollment.
Yes, with conditions, through the Medicare GLP-1 Bridge, a temporary CMS program that runs outside your Part D benefit. The Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027) covers Foundayo for weight loss for $50 per monthly fill if you have Part D coverage and meet CMS’s eligibility criteria. This doesn't affect Marketplace plans.
YOUR PATH FORWARD
What's Next
Foundayo Coverage: Other Insurance Options
Coverage varies significantly by plan type. See our guides for specific insurers:
- Blue Cross Blue Shield — Major 2026 coverage restrictions announced
- Aetna — Most plans cover with prior authorization
- Cigna — Cigna plans may require step therapy; check your plan’s policy
- Medicare — Covered for weight loss through the Medicare GLP-1 Bridge for $50 per monthly fill, with conditions
- Medicaid — State-by-state coverage varies widely
Other GLP-1 Medications on Marketplace Plans
Marketplace coverage varies by medication. Compare your options:
References
- Kaiser Family Foundation (KFF). (2025). "State Health Insurance Marketplace Statistics." Analysis of ACA Marketplace coverage trends. Coverage for weight loss medications varies significantly by state and carrier. kff.org
- GoodRx Research. (2025, November). "Live Updates: Tracking Insurance Coverage for GLP-1 Agonists Like Foundayo and Wegovy." Data sourced from Managed Markets Insight & Technology (MMIT) showing 51% of commercial insurance has no coverage for Foundayo; CVS Caremark removed Foundayo from formulary July 2025. goodrx.com
- Eli Lilly. (2026). "Foundayo Coverage & Savings." Official coverage checker and savings card terms for 2026. Savings card: up to $100/month savings, $1,000/year cap, maximum 10 fills/year. Self-pay via LillyDirect: $149–$299/month by dose. Expires 12/31/2026. foundayo.lilly.com
- American Medical Association (AMA). (2024, October 3). "Over 80% of Prior Auth Appeals Succeed—Why Aren't There More?" Analysis citing KFF data: 39-59% success rate for commercial insurance appeals; 80%+ for Medicare Advantage. ama-assn.org
- Kaiser Family Foundation (KFF). (2025, January). "Claims Denials and Appeals in ACA Marketplace Plans in 2023." Analysis showing 44% internal appeal success rate for ACA plans; less than 1% of denials are appealed. kff.org
- Healthcare.gov. (2026). "Internal Appeals." ACA appeal rights including 180-day filing deadline per 45 CFR § 147.136. healthcare.gov
- Healthcare.gov. (2026). "External Review." External review process: 45-day standard timeline, 72-hour expedited; decisions are binding on insurer. healthcare.gov
- CMS. (2025, October). "Marketplace 2026 Open Enrollment Fact Sheet." Open enrollment November 1, 2025 – January 15, 2026; December 15, 2025 deadline for January 1, 2026 coverage. cms.gov
- Healthcare.gov. (2026). "What Marketplace health insurance plans cover." Overview of 10 essential health benefits under ACA (weight loss drugs not included). healthcare.gov
- Blue Cross Blue Shield of Massachusetts. (2025, November). "2026 Plan Changes." Announced discontinuation of Wegovy, Saxenda, and Zepbound coverage for weight loss effective January 1, 2026; coverage continues for type 2 diabetes and cardiovascular indications. Premium reductions of ~3% attributed to GLP-1 exclusions. Similar coverage cuts announced by NH Healthy Families and MVP of Vermont.
- Centers for Medicare & Medicaid Services. (2025, December 23). "BALANCE Model: Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth." CMS model with Eli Lilly and Novo Nordisk for GLP-1 coverage in Medicare/Medicaid (Part D track delayed with no new start date; Medicaid track voluntary for states). cms.gov
Last updated October 6, 2026
Disclaimer
The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.
While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.